Margarite D. Matossian

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 21 papers. Top paper: “Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model”.

Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model

Oncoscience(2018)10.18632/oncoscience.412

N/A

0.470DataRank · unranked

22 citations

Hope E. Burks, Steven Elliott, Van T. Hoang, Annie C. Bowles, Rachel A. Sabol +5 more

Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer

Women s Health Reports(2020)10.1089/whr.2020.0037

N/A

0DataRank · unranked

10 citations

Alexandra A. Giardina, Maryl Wright, Steven Elliott, Michelle Marie Loch, Khoa Nguyen +11 more

ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer

Frontiers in Oncology(2020)10.3389/fonc.2020.01164

N/A

0DataRank · unranked

23 citations

Margarite D. Matossian, Deniz A. Uçar, Steven Elliott, Jacqueline La, Maryl Wright +20 more

Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes

UNC Libraries(2020)10.17615/2kr8-5z68

N/A

0DataRank · unranked

0 citations

S. R. Elliott, Margarite D. Matossian, Van T. Hoang, David H. Drewry, Carrow I. Wells +6 more

Molecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling

Biomolecules(2021)10.3390/biom11020183

N/A

0DataRank · unranked

31 citations

Saloni Patel, Margarite D. Matossian, Deniz A. Uçar, Lucio Miele, Matthew E. Burow +3 more

Quantifying Breast Cancer-Driven Fiber Alignment and Collagen Deposition in Primary Human Breast Tissue

Frontiers in Bioengineering and Biotechnology(2021)10.3389/fbioe.2021.618448

N/A

0DataRank · unranked

24 citations

C. Ethan Byrne, Loren M. Brown, Rafael Felix P. Tiongco, Margarite D. Matossian, Jonathan J. Savoie +5 more

In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types

Clinical & Translational Oncology(2021)10.1007/s12094-021-02677-8

N/A

0DataRank · unranked

22 citations

Tiffany Chang, Maryl Wright, Hope E. Burks, S G Elliott, Rachel A. Sabol +28 more

NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06295-4

N/A

0DataRank · unranked

19 citations

Steven Elliott, ThiHongNgoc Hoang, Hope E. Burks, Maryl Wright, Madlin Alzoubi +16 more

Diverse and converging roles of ERK1/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer

Translational Oncology(2021)10.1016/j.tranon.2021.101046

N/A

0DataRank · unranked

17 citations

Thomas D. Wright, Van Barnes, Suravi Chakrabarty, Margarite D. Matossian, Erin Lexner +6 more

Targeting Never-In-Mitosis-A Related Kinase 5 in Cancer: A Review

Current Medicinal Chemistry(2021)10.2174/0929867328666210322101749

N/A

0DataRank · unranked

12 citations

Carrow I. Wells, William J. Zuercher, Bridgette M. Collins‐Burow, David H. Drewry, Matthew E. Burow +1 more

Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor

PLoS ONE(2020)10.1371/journal.pone.0226464

N/A

0DataRank · unranked

18 citations

Margarite D. Matossian, Steven Elliott, Hope E. Burks, Rachel A. Sabol, Deniz A. Uçar +11 more

NEK5 Activity Regulates the Mesenchymal and Migratory Phenotype in Breast Cancer Cells

Research Square(2021)10.21203/rs.3.rs-412293/v1

N/A

0DataRank · unranked

2 citations

Steven Elliott, Van T. Hoang, Hope E. Burks, Maryl Wright, Madlin Alzoubi +16 more

ZEB2 Regulates Endocrine Therapy Sensitivity and Metastasis in Luminal A Breast Cancer Through a Non-Canonical Mechanism

Research Square(2021)10.21203/rs.3.rs-390171/v1

N/A

0DataRank · unranked

0 citations

Margarite D. Matossian, Lyndsay V. Rhodes, Theresa B. Phamduy, Steven Elliott, Aaron Buechlein +7 more

Liver Kinase B1 Regulates Remodeling of the Tumor Microenvironment in Triple-Negative Breast Cancer

Frontiers in Molecular Biosciences(2022)10.3389/fmolb.2022.847505

N/A

0DataRank · unranked

7 citations

Margarite D. Matossian, Jonathan J. Savoie, Khoa Nguyen, Maryl Wright, Celia Byrne +9 more

Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer

Frontiers in Immunology(2023)10.3389/fimmu.2023.1244159

N/A

0DataRank · unranked

13 citations

Deniz A. Uçar, Giulia Monticone, Yong Ran, Samarpan Majumder, Kristina Larter +16 more

A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13103

N/A

0DataRank · unranked

3 citations

Poornima Saha, Murtuza Rampurwala, Sailaja Kamaraju, Olwen Hahn, Frederick M. Howard +8 more

High tumor glucocorticoid receptor expression in early-stage, triple-negative breast cancer is associated with increased T-regulatory cell infiltration

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07515-3

N/A

0DataRank · unranked

8 citations

Christine Y. Shiang, Deniz Nesli Dolcen, Marie Dreyer, Ken Hatogai, Katie Hall +8 more

Mechanical Disruption by Focused Ultrasound Re-sensitizes ER+ Breast Cancer Cells to Hormone Therapy

Ultrasound in Medicine & Biology(2024)10.1016/j.ultrasmedbio.2024.08.015

N/A

0DataRank · unranked

3 citations

Rachel A. Sabol, Jeannette Nyiramana, Aimee Twizeyimana, Emma Bortz, Margarite D. Matossian +6 more

NEK Family Kinases: Structure, Function, and Role in Disease

Biomolecules(2025)10.3390/biom15101406

N/A

0DataRank · unranked

4 citations

Julia R. Boehling, Sarah Knopf, S Held, Margarite D. Matossian, Jorge A. Belgodere +8 more

A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07626-5

N/A

0DataRank · unranked

2 citations

Margarite D. Matossian, Poornima Saha, Murtuza Rampurwala, Sailaja Kamaraju, Olwen Hahn +8 more

Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant‑resistant phenotype in breast cancer cells

Oncology Letters(2021)10.3892/ol.2021.12641

N/A

0DataRank · unranked

1 citations

Steven Elliott, Lyndsay V. Rhodes, Elizabeth C. Martin, Van T. Hoang, Hope E. Burks +5 more